BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koutkia P, Mylonakis E, Rounds S, Erickson A. Leucocytoclastic vasculitis: an update for the clinician. Scand J Rheumatol 2001;30:315-22. [PMID: 11846048 DOI: 10.1080/030097401317148499] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen XY, Wu ZM, Wang R, Cao YH, Tao YL. Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report. World J Clin Cases 2022; 10(33): 12422-12429 [DOI: 10.12998/wjcc.v10.i33.12422] [Reference Citation Analysis]
2 Theran león JS, Ascanio JRR, Badillo LYE, Dulcey LA. Vasculitis leucocitoclástica secundaria a infección por COVID-19. Atención Primaria Práctica 2022;4:100135. [DOI: 10.1016/j.appr.2022.100135] [Reference Citation Analysis]
3 Xu S, Han S, Dai Y, Wang L, Zhang X, Ding Y. A Review of the Mechanism of Vascular Endothelial Injury in Immunoglobulin A Vasculitis. Front Physiol 2022;13:833954. [DOI: 10.3389/fphys.2022.833954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kharsa A, Chowdhury M, Tan BE, Abu Sheikha M, Baibhav B. Constrictive Pericarditis: An Unusual Presentation of Rheumatoid Vasculitis. Cureus. [DOI: 10.7759/cureus.21643] [Reference Citation Analysis]
5 Abtahi-naeini B, Fattah M. COVID-19 and Dermatological Manifestations. Atlas of Dermatology, Dermatopathology and Venereology 2022. [DOI: 10.1007/978-3-319-53805-1_100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Farajzadeh S, Khalili M, Dehghani S, Babaie S, Fattah M, Abtahi-Naeini B. Top 10 acral skin manifestations associated with COVID-19: A scoping review. Dermatol Ther 2021;:e15157. [PMID: 34628708 DOI: 10.1111/dth.15157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhu KJ, Yang PD, Xu Q. Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report. Front Immunol 2021;12:695768. [PMID: 34248994 DOI: 10.3389/fimmu.2021.695768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Yi Z, Song N, Chen Z, Fan Y, Liu Y, Zhang B. Autologous platelet-rich plasma in the treatment of refractory wounds in cutaneous leukocytoclastic vasculitis complicated with hypertension (grade 2 moderate risk): A case report. Transfus Apher Sci 2021;60:103157. [PMID: 33972173 DOI: 10.1016/j.transci.2021.103157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Boge H, Almehmi S, Almehmi A. Skin Rash in a Stage 4 CKD Patient Treated for Hyperkalemia. Kidney360 2021;2:176-177. [DOI: 10.34067/kid.0003992020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Abtahi-naeini B, Fattah M. COVID-19 and Dermatological Manifestations. Atlas of Dermatology, Dermatopathology and Venereology 2021. [DOI: 10.1007/978-3-319-45134-3_100-1] [Reference Citation Analysis]
11 Camprodon Gómez M, González-Cruz C, Ferrer B, Barberá MJ. Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy. BMJ Case Rep 2020;13:e238039. [PMID: 33122236 DOI: 10.1136/bcr-2020-238039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
12 Prejac J, Kekez D, Belev B, Kocić L, Bulimbašić S, Pleština S. Leukocytoclastic vasculitis associated with sorafenib treatment for hepatocellular carcinoma. Anticancer Drugs 2020;31:76-9. [PMID: 31567309 DOI: 10.1097/CAD.0000000000000840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Khan TMA, Ansari Y, Siddiqui AH, Ansari SA, Siddiqui F. Development of Central Nervous System Vasculitis in a Patient with Waldenstrom Macroglobulinemia: A Rare Presentation with Poor Prognosis. Cureus 2019;11:e6039. [PMID: 31824806 DOI: 10.7759/cureus.6039] [Reference Citation Analysis]
14 Basu S, Mittal R. Retinal vasculitis associated with cutaneous leukocytoclastic vasculitis. Int Ophthalmol 2019;39:451-3. [PMID: 29256164 DOI: 10.1007/s10792-017-0807-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Quintanilha JCF, Visacri MB, Amaral LS, Lima CSP, Cintra ML, Moriel P. Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report. BMC Cancer 2017;17:831. [PMID: 29212535 DOI: 10.1186/s12885-017-3848-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Kal A, Duman E, Sezenöz AS, Ulusoy MO, Kal Ö. Evaluation of retrobulbar blood flow and choroidal thickness in patients with rheumatoid arthritis. Int Ophthalmol 2018;38:1825-31. [PMID: 28730400 DOI: 10.1007/s10792-017-0656-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cakiter AU, Kucuk OS, Ozkaya DB, Topukcu B, Onsun N. Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis. Postepy Dermatol Alergol 2017;34:104-9. [PMID: 28507487 DOI: 10.5114/ada.2017.67071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
18 Nousari CH, Baze MR. Cutaneous Vasculitis: A Clinical Approach. Clinical and Basic Immunodermatology 2017. [DOI: 10.1007/978-3-319-29785-9_26] [Reference Citation Analysis]
19 Xiao T, Chen H, Gao J, Wang G, Cizenski JD, Gou D, Menter A, Zhao L, Yan R, Wu Y, Yuan J, Xu H, Gao X, Chen H. Multifactorial Diseases with Immunological Involvement. Practical Immunodermatology 2017. [DOI: 10.1007/978-94-024-0902-4_10] [Reference Citation Analysis]
20 Salem CB, Hmouda H, Slim R, Denguezli M, Belajouza C, Bouraoui K. Rare Case of Metformin-Induced Leukocytoclastic Vasculitis. Ann Pharmacother 2006;40:1685-7. [DOI: 10.1345/aph.1h155] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
21 Jumean K, Arqoub AA, Hawatmeh A, Qaqa F, Bataineh A, Shaaban H. Warfarin-induced leukocytoclastic vasculitis and proteinuria. J Family Med Prim Care 2016;5:160-2. [PMID: 27453863 DOI: 10.4103/2249-4863.184643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
22 Duru N, Altinkaynak H, Erten Ş, Can ME, Duru Z, Uğurlu FG, Çağıl N. Thinning of Choroidal Thickness in Patients with Rheumatoid Arthritis Unrelated to Disease Activity. Ocular Immunology and Inflammation 2015;24:246-53. [DOI: 10.3109/09273948.2015.1024329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
23 Agrawal SR, Rajput A, Jain AP. Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure. J Pharmacol Pharmacother 2014;5:268-70. [PMID: 25422573 DOI: 10.4103/0976-500X.142453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
24 Kobak S, Yilmaz H, Karaarslan A, Yalcin M. Leukocytoclastic vasculitis in a patient with ankylosing spondylitis. Case Rep Rheumatol 2014;2014:653837. [PMID: 24653851 DOI: 10.1155/2014/653837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
25 Chakraborty S, Dimaio D, Vanschooneveld T. Palpable maculopapular rash with elevated ESR: what is your diagnosis? Ups J Med Sci 2013;118:285-6. [PMID: 23977865 DOI: 10.3109/03009734.2013.831504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Bhattacharyya A, Yeddula K, Nwankwo N, Senussi MH. Leucocytoclastic vasculitis. BMJ Case Rep 2013;2013:bcr2013009408. [PMID: 23580692 DOI: 10.1136/bcr-2013-009408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Rocha G, Mednick ZD. Progressive Cicatrizing Endotheliitis Associated with Leucocytoclastic Vasculitis and Crohn Disease. Ocular Immunology and Inflammation 2013;21:241-3. [DOI: 10.3109/09273948.2012.761241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Lee JJ, Kim Y, Shin JI, Yim H, Park SJ. Clinicopathologic Changes in Children with Immunoglobulin A Nephritis and Henoch-Schönlein Purpura Nephritis after Cyclosporine A and Angiotensin-converting Enzyme Inhibitor Treatment. J Korean Soc Pediatr Nephrol 2013;17:92. [DOI: 10.3339/jkspn.2013.17.2.92] [Reference Citation Analysis]
29 Munisamy R, Uppalu H, Raghavendra R, Venkata NP, Harshita S, Janarthanam SV. Type-I complex regional pain syndrome of umbilical port site: An unforeseen complication of laparoscopic surgery. J Minim Access Surg 2012;8:50-3. [PMID: 22623826 DOI: 10.4103/0972-9941.95535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
30 Machaczka M, Klimkowska M, Hägglund H. Unexpected cure from cutaneous leukocytoclastic vasculitis in a patient treated with N-butyldeoxynojirimycin (miglustat) for Gaucher disease. Adv Med Sci 2012;57:169-73. [PMID: 22515974 DOI: 10.2478/v10039-012-0021-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
31 Li YY, Li CR, Wang GB, Yang J, Zu Y. Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura. Rheumatol Int 2012;32:3785-92. [PMID: 22187057 DOI: 10.1007/s00296-011-2266-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
32 Sipponen T, Virolainen S, Arkkila P. A patient with ulcerative colitis and an unusual rash. Gastroenterology 2010;139:e5-6. [PMID: 21029804 DOI: 10.1053/j.gastro.2009.12.070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
33 Chung MP, Yi CA, Lee HY, Han J, Lee KS. Imaging of pulmonary vasculitis. Radiology 2010;255:322-41. [PMID: 20413748 DOI: 10.1148/radiol.10090105] [Cited by in Crossref: 98] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
34 Shin JI, Lee SJ, Lee JS, Kim KH. Intravenous dexamethasone followed by oral prednisolone versus oral prednisolone in the treatment of childhood Henoch-Schönlein purpura. Rheumatol Int 2011;31:1429-32. [PMID: 20464400 DOI: 10.1007/s00296-010-1507-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Tripodi Cutrì F, Salerno R, Lo Schiavo A, Gravina AG, Romano M, Ruocco E. Ulcerative colitis associated with leukocytoclastic vasculitis of the skin. Dig Liver Dis 2009;41:e42-4. [PMID: 18799375 DOI: 10.1016/j.dld.2008.06.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
36 Fretzayas A, Sionti I, Moustaki M, Papadimitriou A, Nicolaidou P. Henoch-Schönlein purpura: a long-term prospective study in Greek children. J Clin Rheumatol 2008;14:324-31. [PMID: 18703982 DOI: 10.1097/RHU.0b013e31817a240a] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
37 DAS M, Chhabra R, Hinton SW. Cutaneous leukocytoclastic vasculitis and myelodysplastic syndrome with little or no evidence of associated autoimmune disorders-a case report and a brief review of the literature. Am J Med Sci 2008;336:368-71. [PMID: 18854686 DOI: 10.1097/MAJ.0b013e31815e8c0b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
38 Ibrahim SF, Nousari CH. Cutaneous Vasculitis. Clinical and Basic Immunodermatology. [DOI: 10.1007/978-1-84800-165-7_19] [Reference Citation Analysis]
39 Tanasescu C, Jurcut C, Jurcut R, Ginghina C. Vascular disease in rheumatoid arthritis: from subclinical lesions to cardiovascular risk. Eur J Intern Med. 2009;20:348-354. [PMID: 19524171 DOI: 10.1016/j.ejim.2008.09.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
40 Gallerani M, Boari B, Sighinolfi L, Govoni M. Leukocytoclastic Vasculitis and Dysesthesias in Lower Limbs. Infectious Diseases in Clinical Practice 2008;16:194-197. [DOI: 10.1097/ipc.0b013e318157d298] [Reference Citation Analysis]
41 Hung JT, Yang YH, Hsiao CH, Yu HH, Lee JH, Wang LC, Chiang BL. Leukocytoclastic vasculitis with severe cardiac involvement in an infant: a case report. Clin Rheumatol 2008;27:945-7. [PMID: 18368289 DOI: 10.1007/s10067-008-0872-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
42 Tuncer S, Bello-rojas G, Blake M, Jackson IT. Surgical treatment of a severe microstomia developed following leucocytoclastic vasculitis. Eur J Plast Surg 2007;30:183-7. [DOI: 10.1007/s00238-007-0170-6] [Reference Citation Analysis]
43 Brandt HRC, Arnone M, Valente NYS, Criado PR, Sotto MN. Vasculite cutânea de pequenos vasos: etiologia, patogênese, classificação e critérios diagnósticos - Parte I. An Bras Dermatol 2007;82:387-406. [DOI: 10.1590/s0365-05962007000500002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
44 Bilku D, Brammer C. A Case of Hypersensitivity Vasculitis after Vinorelbine Injection in a Patient with Metastatic Breast Cancer. Clinical Oncology 2007;19:363-4. [DOI: 10.1016/j.clon.2007.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
45 Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 2006;36:88-98. [PMID: 17023257 DOI: 10.1016/j.semarthrit.2006.04.006] [Cited by in Crossref: 115] [Cited by in F6Publishing: 120] [Article Influence: 7.2] [Reference Citation Analysis]
46 Kristen A, Borst M, Andrassy K, Kirschfink M, Müller-quernheim J, Katus H, Meyer F. Anti-oxidant and anti-inflammatory therapy in hypocomplementemic urticarial vasculitis with pulmonary emphysema. Respiratory Medicine Extra 2007;3:147-51. [DOI: 10.1016/j.rmedx.2007.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
47 Lado Lema P, Otero Palleiro M, Barbagelata López C. Sífilis latente tardía: manifestaciones cutáneas. FMC - Formación Médica Continuada en Atención Primaria 2006;13:630-631. [DOI: 10.1016/s1134-2072(06)71420-7] [Reference Citation Analysis]
48 Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura. Scand J Rheumatol 2006;35:56-60. [PMID: 16467044 DOI: 10.1080/03009740510026841] [Cited by in Crossref: 72] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
49 Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ. Methylprednisolone pulse therapy by the Tune-Mendoza protocol in a child with severe Henoch-Schönlein nephritis. Scand J Rheumatol 2006;35:162-3. [PMID: 16641057 DOI: 10.1080/03009740500304361] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
50 Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment. Scand J Rheumatol 2005;34:392-5. [PMID: 16234188 DOI: 10.1080/03009740510026544] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
51 Glaich AS, Krathen RA, Smith MJ, Hsu S. Disseminated candidiasis mimicking leukocytoclastic vasculitis. Journal of the American Academy of Dermatology 2005;53:543-5. [DOI: 10.1016/j.jaad.2005.03.059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
52 Manoharan S, Muir J. Gallbladder vasculitis associated with cutaneous leucocytoclastic vasculitis. Australas J Dermatol 2004;45:216-9. [PMID: 15527431 DOI: 10.1111/j.1440-0960.2004.00100.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
53 van Rossum AP, Fazzini F, Limburg PC, Manfredi AA, Rovere-Querini P, Mantovani A, Kallenberg CG. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum 2004;50:2667-74. [PMID: 15334483 DOI: 10.1002/art.20370] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
54 Moore PM, Villringer A. The Vasculitides. Neurological Disorders 2003. [DOI: 10.1016/b978-012125831-3/50233-1] [Reference Citation Analysis]
55 Faust D, Akoglu B, Zgouras D, Scheuermann EH, Milovic V, Stein J. Anti-inflammatory drugs modulate C1q secretion in human peritoneal macrophages in vitro. Biochem Pharmacol 2002;64:457-62. [PMID: 12147297 DOI: 10.1016/s0006-2952(02)01183-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]